文献速递胰腺与胆道疾病

特发性胰腺炎患者中致病性PRSS1、SPINK1、CFTR和/或CTRC基因变异相关因素评估

An Evaluation of Factors Associated With Pathogenic PRSS1, SPINK1, CTFR, and/or CTRC Genetic Variants in Patients With Idiopathic Pancreatitis.
PubMed 文献 · Am J Gastroenterol · 2017-04-25

研究纳入2010至2015年197例特发性胰腺炎患者,其中134例接受PRSS1、CFTR、SPINK1和CTRC基因检测,64例(47.8%)检出致病性基因变异;校正分析显示急性复发性特发性胰腺炎(OR 18.12)和年龄<35岁不明原因首次急性胰腺炎(OR 2.46)与致病性基因变异独立相关,而特发性慢性胰腺炎无此关联。

要点

  • 134例接受基因检测的特发性胰腺炎患者中64例(47.8%)检出致病性基因变异。
  • 急性复发性特发性胰腺炎与致病性基因变异独立相关(OR 18.12)。
  • 年龄<35岁不明原因首次急性胰腺炎与致病性基因变异独立相关(OR 2.46)。

核心结论

  • 致病性基因变异最可能在急性复发性特发性胰腺炎和年龄<35岁不明原因首次急性胰腺炎患者中检出。
  • 在这些人群中进行基因检测可能明确病因并避免不必要的诊断性检查和操作。

研究设计与样本

  • 2010至2015年间对符合条件的所有特发性胰腺炎患者进行PRSS1、CFTR、SPINK1和CTRC基因检测。
  • 根据病历回顾将患者分为四组:急性复发性特发性胰腺炎(伴或不伴 underlying 慢性胰腺炎)、无急性复发性胰腺炎病史的特发性慢性胰腺炎、年龄<35岁不明原因首次急性胰腺炎、胰腺炎家族史。
  • 采用逻辑回归分析确定与致病性基因变异相关的因素。
  • 2010至2015年评估的197例急性复发性特发性胰腺炎和/或特发性慢性胰腺炎患者中,134例接受了基因检测。

主要发现

  • 134例接受基因检测的患者中,64例(47.8%)共检出88个致病性基因变异。
  • 急性复发性特发性胰腺炎患者中致病性基因变异检出率为58%,年龄<35岁不明原因首次急性胰腺炎为63%,无急性复发性胰腺炎病史的特发性慢性胰腺炎为27%。
  • 校正分析中,急性复发性特发性胰腺炎(OR 18.12;95% CI 2.16-151.87;P=0.008)和年龄<35岁不明原因首次急性胰腺炎(OR 2.46;95% CI 1.18-5.15;P=0.017)与致病性基因变异独立相关,而特发性慢性胰腺炎无此关联。

临床怎么用

  • 作者认为,在急性复发性特发性胰腺炎和年龄<35岁不明原因首次急性胰腺炎患者中进行基因检测可能明确病因并避免不必要的诊断性检查和操作。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We evaluated factors associated with pathogenic genetic variants in patients with idiopathic pancreatitis. METHODS: Genetic testing (PRSS1, CFTR, SPINK1, and CTRC) was performed in all eligible patients with idiopathic pancreatitis between 2010 to 2015. Patients were classified into the following groups based on a review of medical records: (1) acute recurrent idiopathic pancreatitis (ARIP) with or without underlying chronic pancreatitis; (2) idiopathic chronic pancreatitis (ICP) without a history of ARP; (3) an unexplained first episode of acute pancreatitis (AP)<35 years of age; and (4) family history of pancreatitis. Logistic regression analysis was used to determine the factors associated with pathogenic genetic variants. RESULTS: Among 197 ARIP and/or ICP patients evaluated from 2010 to 2015, 134 underwent genetic testing. A total of 88 pathogenic genetic variants were found in 64 (47.8%) patients. Pathogenic genetic variants were identified in 58, 63, and 27% of patients with ARIP, an unexplained first episode of AP <35 years of age, and ICP without ARP, respectively. ARIP (OR: 18.12; 95% CI: 2.16-151.87; P=0.008) and an unexplained first episode of AP<35 years of age (OR: 2.46; 95% CI: 1.18-5.15; P=0.017), but not ICP, were independently associated with pathogenic genetic variants in the adjusted analysis. CONCLUSIONS: Pathogenic genetic variants are most likely to be identified in patients with ARIP and an unexplained first episode of AP<35 years of age. Genetic testing in these patient populations may delineate an etiology and prevent unnecessary diagnostic testing and procedures.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Jalaly NY, Moran RA, Fargahi F, et al. An Evaluation of Factors Associated With Pathogenic PRSS1, SPINK1, CTFR, and/or CTRC Genetic Variants in Patients With Idiopathic Pancreatitis. Am J Gastroenterol. 2017. PMID: 28440306. doi:10.1038/ajg.2017.106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。